Intrathecal ketorolac enhances antinociception from clonidine

Anesthesia and Analgesia

Volumn 96, Issue 1, 2003, Pages 191-194

  Conklin, Dawn R ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; KETOROLAC; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLONIDINE; DRUG SYNERGISM; HEAT; INJECTIONS, SPINAL; KETOROLAC; MALE; PAIN MEASUREMENT; RATS; TIME FACTORS;

EID: 0037222757     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200301000-00040     Document Type: Article

References (24)

1. Maihöfner C, Tegeder I, Euchenhofer C, et al. Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience 2000;101: 1093-1108.
2. 2 release in spinal cord slices: Relative effect of cyclooxygenase inhibitors. Eur J Pharmacol 1994;271:293-9.
3. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993;79:270-81.
4. Tejwani GA, Rattan AK. Antagonism of antinociception produced by intrathecal clonidine by ketorolac in the rat: The role of the opioid system. Anesth Analg 2000;90:1152-6.
5. Taiwo YO, Levine JD. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J Neurosci 1988;8:1346-9.
6. Howe JR, Yaksh TL, Go VL. The effect of unilateral dorsal root ganglionectomies or ventral rhizotomies on α2-adrenoceptor binding to, and the substance p, enkephalin, and neurotensin content of, the cat lumbar spinal cord. Neuroscience 1987;21: 385-94.
7. Kuraishi Y, Hirota N, Sato Y, et al. Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res 1985;359:177-82.
8. Bourgoin S, Pohl M, Mauborgne A, et al. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices. Neuropharmacology 1993;32:633-40.
9. Kamisaki Y, Hamada T, Maeda K, et al. Presynaptic α2 adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. J Neurochem 1993;60:522-6.
10. North RA, Yoshimura M. The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J Physiol 1984; 349:43-55.
11. 2-adrenoceptor stimulation in the guinea-pig spinal cord slices. Pharmacol Toxicol 1988;63:178-82.
12. Baba H, Kohno T, Moore KA, Woolf CJ. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 2001;21:1750-6.
13. Zhang ZZ, Hefferan MP, Loomis CW. Topical bicuculline to the rat spinal cord induces highly localized allodynia that is mediated by spinal prostaglandins. Pain 2001;92:351-61.
14. Syriatowicz J-P, Hu D, Walker JS, Tracey DJ. Hyperalgesia due to nerve injury: Role of prostaglandins. Neuroscience 1999;94: 587-94.
15. Kawahara H, Sakamoto A, Takeda S, et al. A prostaglandin e(2) receptor subtype ep(1) receptor antagonist (ono-8711) reduces hyperalgesia, allodynia, and c-fos gene expression in rats with chronic nerve constriction. Anesth Analg 2001;93:1012-7.
16. 2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 2001;107:325-31.
17. 3 receptor knockout mice. Br J Pharmacol 2001;133:438-44.
18. 2 Selectivity ratio in a series of agonists and their relation to pre/postsynaptic activity ratios. Eur J Pharmacol 1983;91:129-33.
19. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989; 45:947-61.
20. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994;59:9-43.
21. 2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001;21:5847-53.
22. Zhao Z, Chen SR, Eisenach JC, et al. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience 2000;97:743-8.
23. 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth Analg 1993;77:104-9.
24. Eisenach JC, DuPen S, Dubois M, et al. Epidural clonidine analgesia for intractable cancer pain. Pain 1995;61:391-9.